14th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG

December 8th ,2025

ONLINE MEETINGS

14th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG

December 8th ,2025

ONLINE MEETINGS

Pitch Sessions

BIOFIT'S PITCH SESSIONS

START-UP SLAMS

Ready to showcase your innovation?

The Start-up Slams are a great opportunity for young companies (and particularly start-ups seeking to raise a seed or a Series A financing round) to showcase their project in front of potential partners and investors in the Life Sciences field.

The selected candidates will have the chance to present their project and receive advice and feedback (“speed-mentoring”) from a panel of experts.

The winner(s) will be recognised as the most innovative start-up(s) in Europe in Life Sciences.

Testimonial

Winner of the BioFIT 2023 Start-up Slams

“This award is not just a recognition of our innovative approach but also a testament to the potential impact of our early blood tests for Alzheimer’s pre-dementia. It’s a significant step in our journey to revolutionise the way we detect and fight this challenging disease.” Baptiste Billoir, co-founder, AgenT-biotech

COLLABORATIVE AND LICENSING OPPORTUNITY PRESENTATIONS

Ready to showcase your technology?

The Collaborative and Licensing Opportunity Presentations are a great opportunity for TTOs, universities, research institutes and companies to showcase their early-stage technologies in front of potential partners in the Life Sciences field, in order to entail a collaborative project and/or a licensing deal.

The selected candidates will have the chance to present and promote their assets in front of the BioFIT participants.

The winner(s) will be recognised as the most promising early-stage technology(ies) in Europe in Life Sciences.

Testimonial

Winner of the BioFIT 2024 Collaborative and Licensing Opportuinity Presentations

“Winning the BioFIT 'Collaborative and Licensing Opportunity' award was very exciting for Brenus Pharma's team! The jury's insightful questions helped us getting further in the presentation of our Stimulated Ghost Cells technology. With our clinical trial launching next quarter, we're eager to demonstrate safety data and open doors to partnerships exploring combinations with therapies such as checkpoint inhibitors and antibody-drug conjugates. BioFIT gave us the platform we needed at this critical stage.” Paul Bravetti, Chief Executive Officer, Brenus Pharma

ANIMAL HEALTH PRESENTATIONS

Co-organised by:

 

Supported by:

The Animal Health Presentations are a great opportunity for young companies, TTOs, universities, research institutes and companies to showcase their innovative project in front of potential partners and investors in the Animal Health sector.

The selected candidates will be offered to present their project and receive advice and feedback (“speed-mentoring”) from a panel of experts.

The winner(s) will be recognised as the most innovative project(s) in Europe in Animal Health.

Sponsors

Contact

Vincent Tavernier

Scroll to Top
  • No products in the cart.